Q-linea AB (CHIX:QLINES) Other Long-Term Liabilities: kr28.41 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:QLINES Q-linea AB CHIX:QLINES
66 GF Score
Price kr1,610.00
GF Value kr1,776.96
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Other Long-Term Liabilities?

Q-linea AB CHIX:QLINES 66 Other Long-Term Liabilities is kr28.41 Mil as of Jun. 2026. GuruFocus rates CHIX:QLINES with a GF Score™ of 66/100 and a GF Value™ of kr1,776.96. The stock has 3 warning signs investors should review.

Q-linea AB's other long-term liabilities for the quarter that ended in Jun. 2026 was kr28.41 Mil.

Q-linea AB's quarterly other long-term liabilities declined from Dec. 2025 (kr-0.00 Mil) to Mar. 2026 (kr-0.10 Mil) but then increased from Mar. 2026 (kr-0.10 Mil) to Jun. 2026 (kr28.41 Mil).

Q-linea AB's annual other long-term liabilities declined from Dec. 2023 (kr0.00 Mil) to Dec. 2024 (kr0.00 Mil) and declined from Dec. 2024 (kr0.00 Mil) to Dec. 2025 (kr-0.00 Mil).

Q-linea AB Other Long-Term Liabilities Related Terms

Q-linea AB Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Other Long-Term Liabilities Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 -0.00

Q-linea AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.10 28.41
CHIX:QLINES
66GF Score
Q-linea AB CHIX:QLINES
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of kr28.41 Mil mean?
Q-linea AB (CHIX:QLINES) has a Other Long-Term Liabilities of kr28.41 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Q-linea AB and its competitors.
Is Q-linea AB's Other Long-Term Liabilities too high?
Q-linea AB's current Other Long-Term Liabilities is kr28.41 Mil. Overall, Q-linea AB has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Other Long-Term Liabilities compare to ABT and SYK?
Q-linea AB's Other Long-Term Liabilities of kr28.41 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Q-linea AB and its competitors. Q-linea AB's current Other Long-Term Liabilities is kr28.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (CHIX:QLINES) has a current Other Long-Term Liabilities of kr28.41 Mil. The stock's GF Value™ is kr1,776.96, compared to a current price of kr1,610.00 — trading 9.4% below its estimated fair value. The current Other Long-Term Liabilities is kr28.41 Mil. Q-linea AB's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Q-linea AB (CHIX:QLINES), the current Other Long-Term Liabilities is kr28.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (CHIX:QLINES) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr1,610.00 is trading 9.4% below its estimated GF Value™ of kr1,776.96.

Key valuation signals for CHIX:QLINES:

  • Other Long-Term Liabilities: kr28.41 Mil
  • GF Value™: kr1,776.96 vs. price of kr1,610.00 (9.4% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the CHIX:QLINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
66GF Score

Get the complete analysis for CHIX:QLINES

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,610.00
Price
kr1,776.96
GF Value